
|Podcasts|March 4, 2021
Podcast: Find out more about Allergan’s presbyopia drop NDA filing
Potential presbyopia treatment coming
Advertisement
Learn more about the recent new drug application (NDA) Allergan submitted for its investigational eyedrop to treat presbyopia. Optometry Times® Editor in Chief Gretchyn Bailey, NCLC, FAAO, chats with Michael Robinson, MD, vice president, global therapeutic area head of ophthalmology at Allergan, to get details on when ODs could discuss a potential presbyopia treatment with their patients.
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
VSP Vision and the American Optometric Association collaborate on doctor contracting commitment
2
AOA+ announces plans to offer over 2000 travel grants for Optometry's Meeting 2026
3
AOAExcel endorses VisionHQ, empowering optometric practices to transform patient relationships with in-office membership plans
4
Regeneron's Eylea HD injection 8 mg approved by FDA for the treatment of macular edema following RVO
5


















































.png)


